Novo Nordisk's total assets for Q4 2024 were kr465.80B, an increase of 17.20% from the previous quarter. NVO total liabilities were kr322.31B for the fiscal quarter, a 16.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.